• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Renalytix plc

    Commencement of trading on OTCQB in the United States
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Medicare Issues Final Coverage Determination for kidneyintelX.dkd
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Announces Financing with Expected Size of up to $4 Million
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Reports Full Year Fiscal 2023 Results
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Announces Middle East Distribution Agreement with Vector Pharma
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    New Published Real-World Evidence Shows KidneyIntelX™ Utility
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
    From Renalytix plc
    Via GlobeNewswire
    Tickers RNLX
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.